Sjögren’s syndrome (SS) is a systemic autoimmune disorder characterized by chronic inflammation, oxidative stress, and progressive salivary gland dysfunction. Current therapies remain limited in efficacy.
Aim:
This study explored the regulatory effect of exosome (Exo)-transported miR-23b-3p on the IκB kinase alpha (IKKα)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling axis in SS.
Methods:
Key SS-related microRNAs (miRNAs) were identified by integrating weighted gene co-expression network analysis with machine-learning-based transcriptomic profiling. Target genes and functional pathways were analyzed by bioinformatics methods. The direct binding between miR-23b and IKKα (CHUK) was validated by a dual-luciferase reporter assay. An in vitro SS cell model was established to examine the effects of miR-23b-3p on the IKKα/NF-κB pathway, oxidative stress, inflammation, and apoptosis. miR-23b-3p was loaded into salivary gland epithelial cell-derived Exos (SGEC-Exos) via electroporation. In vitro coculture experiments assessed reactive oxygen species (ROS) levels, inflammatory cytokines, Treg/Th17 balance, and cell apoptosis. In vivo effects were evaluated in NOD/Ltj mice by measuring salivary flow rate, histopathology, and expression of salivary-function-related proteins AQP5 and GPER.
Results:
SGEC-Exos@miR-23b-3p significantly suppressed IKKα expression and NF-κB activation, reduced ROS production, and modulated immune responses by restoring the Treg/Th17 balance. It also inhibited apoptosis by decreasing Bax and caspase-3 expression and increasing Bcl-2 levels. These effects were partially reversed by reactivation of the IKKα/NF-κB pathway. In NOD/Ltj mice, SGEC-Exos@miR-23b-3p improved salivary flow, alleviated glandular pathology, and upregulated AQP5 and GPER expression.
Conclusions:
SGEC-Exos@miR-23b-3p offers a translational approach to address oxidative stress, immune imbalance, and glandular injury in SS, highlighting the potential of Exo-based miRNA therapy. Antioxid. Redox Signal. 00, 000–000.
ArgyropoulouOD, ValentiniE, FerroF, et al.One year in review 2018: Sjögren’s syndrome. Clin Exp Rheumatol2018;36 Suppl 112(3):14–26.
2.
BjordalO, NorheimKB, RødahlE, et al.Primary Sjögren’s syndrome and the eye. Surv Ophthalmol2020;65(2):119–132; doi: 10.1016/j.survophthal.2019.10.004
3.
BurrowsK, Figueroa-HallLK, AlarbiAM, et al.Association between inflammation, reward processing, and ibuprofen-induced increases of miR-23b in astrocyte-enriched extracellular vesicles: A randomized, placebo-controlled, double-blind, exploratory trial in healthy individuals. Brain Behav Immun Health2023;27:100582; doi: 10.1016/j.bbih.2022.100582
4.
CafaroG, CroiaC, ArgyropoulouOD, et al.One year in review 2019: Sjögren’s syndrome. Clin Exp Rheumatol2019;37 Suppl 118(3):3–15.
5.
CaoC, ZhangY, ChaiY, et al.Attenuation of sepsis-induced cardiomyopathy by regulation of MicroRNA-23b is mediated through targeting of MyD88-mediated NF-κB activation. Inflammation2019;42(3):973–986; doi: 10.1007/s10753-019-00958-7
6.
ChangYL, LinCS, WangHW, et al.Chlorpheniramine attenuates histamine-mediated aquaporin 5 downregulation in human nasal epithelial cells via suppression of NF-κB activation. Int J Med Sci2017;14(12):1268–1275; doi: 10.7150/ijms.21573
7.
CharoenviriyakulC, TakahashiY, NishikawaM, et al.Preservation of exosomes at room temperature using lyophilization. Int J Pharm2018;553(1–2):1–7; doi: 10.1016/j.ijpharm.2018.10.032
8.
ChenJQ, PappG, PóliskaS, et al.MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren’s syndrome. PLoS One2017;12(3):e0174585; doi: 10.1371/journal.pone.0174585
9.
ChenJQ, PappG, SzodorayP, et al.The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev2016;15(12):1171–1180; doi: 10.1016/j.autrev.2016.09.003
10.
ChivassoC, D’AgostinoC, ParisisD, et al.Involvement of aquaporin 5 in Sjögren’s syndrome. Autoimmun Rev2023;22(3):103268; doi: 10.1016/j.autrev.2023.103268
11.
FengX, LuJ, ChengW, et al.LTK deficiency induces macrophage M2 polarization and ameliorates Sjogren’s syndrome by reducing chemokine CXCL13. Cytokine2025;190:156905; doi: 10.1016/j.cyto.2025.156905
12.
FerreiraD, MoreiraJN, RodriguesLR. New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol Hematol2022;172:103628; doi: 10.1016/j.critrevonc.2022.103628
FuL, ZhaoZ, ZhaoS, et al.The involvement of aquaporin 5 in the inflammatory response of primary Sjogren’s syndrome dry eye: Potential therapeutic targets exploration. Front Med (Lausanne)2024;11:1439888; doi: 10.3389/fmed.2024.1439888
15.
GaoJ, KilledarS, CorneliusJG, et al.Sjögren’s syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J Autoimmun2006;26(2):90–103; doi: 10.1016/j.jaut.2005.11.004
16.
HoseinzadehA, RezaieyazdiZ, MahmoudiM, et al.Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic? Int Immunopharmacol2023;117:109699; doi: 10.1016/j.intimp.2023.109699
17.
HuS, ChenB, ZhouJ, et al.Dental pulp stem cell-derived exosomes revitalize salivary gland epithelial cell function in NOD mice via the GPER-mediated cAMP/PKA/CREB signaling pathway. J Transl Med2023;21(1):361; doi: 10.1186/s12967-023-04198-0
18.
HuX, ZhengX. Commentary: Understanding ESL teachers’ agency in their early years of professional development: A three-layered triadic reciprocity framework. Front Psychol2022;13:890098; doi: 10.3389/fpsyg.2022.890098
19.
Ibáñez-CabellosJS, Seco-CerveraM, Osca-VerdegalR, et al.Epigenetic regulation in the pathogenesis of Sjögren syndrome and rheumatoid arthritis. Front Genet2019;10:1104; doi: 10.3389/fgene.2019.01104
20.
JangWY, HwangJY, ChoJY. Ginsenosides from Panax ginseng as key modulators of NF-κB signaling are powerful anti-inflammatory and anticancer agents. Int J Mol Sci2023;24(7):6119; doi: 10.3390/ijms24076119
21.
KarinM, Ben-NeriahY. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol2000;18:621–663; doi: 10.1146/annurev.immunol.18.1.621
22.
KoscianskaE, Starega-RoslanJ, SznajderLJ, et al.Northern blotting analysis of microRNAs, their precursors and RNA interference triggers. BMC Mol Biol2011;12:14; doi: 10.1186/1471-2199-12-14
23.
LinJ, YangL, LiuT, et al.Mannose-modified exosomes loaded with MiR-23b-3p target alveolar macrophages to alleviate acute lung injury in Sepsis. J Control Release2025;379:832–847; doi: 10.1016/j.jconrel.2025.01.073
24.
LustigKA, CoteKA, WilloughbyT. The role of pubertal status and sleep satisfaction in emotion reactivity and regulation in children and adolescents. Sleep Adv2021;2(1):zpab003; doi: 10.1093/sleepadvances/zpab003
25.
MougeotJC, ThornburgTE, NollBD, et al.Regulation of STAT1 and STAT4 expression by growth factor and interferon supplementation in Sjögren’s syndrome cell culture models. Int J Mol Sci2024;25(6):3166; doi: 10.3390/ijms25063166
26.
NegriniS, EmmiG, GrecoM, et al.Sjögren’s syndrome: A systemic autoimmune disease. Clin Exp Med2022;22(1):9–25; doi: 10.1007/s10238-021-00728-6
27.
OgawaY, TakeuchiT, TsubotaK. Autoimmune epithelitis and chronic inflammation in Sjögren’s syndrome-related dry eye disease. Int J Mol Sci2021;22(21):11820; doi: 10.3390/ijms222111820
28.
OrtegaA, Martinez-ArroyoO, FornerMJ, et al.Exosomes as drug delivery systems: Endogenous nanovehicles for treatment of systemic lupus erythematosus. Pharmaceutics2020;13(1):3; doi: 10.3390/pharmaceutics13010003
29.
OrtizGGR, ZaidiNH, SainiRS, et al.The developing role of extracellular vesicles in autoimmune diseases: Special attention to mesenchymal stem cell-derived extracellular vesicles. Int Immunopharmacol2023;122:110531; doi: 10.1016/j.intimp.2023.110531
30.
ParisisD, ChivassoC, PerretJ, et al.Current state of knowledge on primary Sjögren’s syndrome, an autoimmune exocrinopathy. J Clin Med2020;9(7):2299; doi: 10.3390/jcm9072299
31.
PeckAB, NguyenCQ. What can Sjögren’s syndrome-like disease in mice contribute to human Sjögren’s syndrome? Clin Immunol2017;182:14–23; doi: 10.1016/j.clim.2017.05.001
32.
PingH, YangF, WangM, et al.IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer. Oncol Rep2016;36(3):1658–1664; doi: 10.3892/or.2016.4915
33.
PuY, HeY, ZhaoX, et al.Depression-like behaviors in mouse model of Sjögren’s syndrome: A role of gut-microbiota-brain axis. Pharmacol Biochem Behav2022;219:173448; doi: 10.1016/j.pbb.2022.173448
34.
RihabB, LinaEH, NoémieST, et al.The experience of dry mouth and screening for Sjogren’s syndrome by the dentist: Patient-reported experiences. BMC Oral Health2023;23(1):1010; doi: 10.1186/s12903-023-03727-z
35.
Romero-LópezMJ, Jiménez-WencesH, Cruz-De la RosaMI, et al.miR-23b-3p, miR-124-3p and miR-218-5p synergistic or additive effects on cellular processes that modulate cervical cancer progression? A molecular balance that needs attention. Int J Mol Sci2022;23(21):13551; doi: 10.3390/ijms232113551
36.
RoszkowskaAM, OliverioGW, AragonaE, et al.Ophthalmologic manifestations of primary Sjögren’s syndrome. Genes (Basel)2021;12(3):365; doi: 10.3390/genes12030365
37.
SantosA, DominguesC, JarakI, et al.Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach. Eur J Pharm Biopharm2022;170:91–111; doi: 10.1016/j.ejpb.2021.12.003
38.
ScuronMD, FayB, OliverJ, et al.Spontaneous model of Sjögren’s syndrome in NOD mice. Curr Protoc Pharmacol2019;86(1):e65; doi: 10.1002/cpph.65
39.
ShaoJ, ZaroJ, ShenY. Advances in exosome-based drug delivery and tumor targeting: From tissue distribution to intracellular fate. Int J Nanomedicine2020;15:9355–9371; doi: 10.2147/IJN.S281890
40.
ShiH, YuCQ, XieLS, et al.Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren’s syndrome in NOD/Ltj mouse. J Oral Pathol Med2014;43(10):785–791; doi: 10.1111/jop.12209
41.
SistoM, RibattiD, LisiS. Understanding the complexity of Sjögren’s syndrome: Remarkable progress in elucidating NF-κB mechanisms. J Clin Med2020;9(9):2821; doi: 10.3390/jcm9092821
42.
SuhJH, JooHS, HongEB, et al.Therapeutic application of exosomes in inflammatory diseases. Int J Mol Sci2021;22(3):1144; doi: 10.3390/ijms22031144
43.
SunX, ZhengX, ZhangX, et al.Exosomal microRNA-23b-3p from bone marrow mesenchymal stem cells maintains T helper/Treg balance by downregulating the PI3k/Akt/NF-κB signaling pathway in intracranial aneurysm. Brain Res Bull2020;165:305–315; doi: 10.1016/j.brainresbull.2020.09.003
44.
TakakuraM, MizutaniA, KudoM, et al.Goji berry juice prevents tumor necrosis factor alpha-induced xerostomia in human salivary gland cells. Biol Pharm Bull2024;47(1):138–144; doi: 10.1248/bpb.b23-00456
45.
WangD, ZhaoH, LiB, et al.Mechanism of cAMP-PKA signaling pathway mediated by shaoyao gancao decoction on regulation of aquaporin 5 and muscarinic receptor 3 levels in Sjögren’s syndrome. Chin J Integr Med2020;26(7):502–509; doi: 10.1007/s11655-020-3205-5
46.
WangW, YueC, GaoS, et al.Promising roles of exosomal microRNAs in systemic lupus erythematosus. Front Immunol2021;12:757096; doi: 10.3389/fimmu.2021.757096
47.
WangX, WuH, ZhongB, et al.Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren’s syndrome. Clin Rheumatol2024;43(12):3781–3787; doi: 10.1007/s10067-024-07190-1
48.
WeiB, HuangH, CaoQ, et al.Bibliometric and visualized analysis of the applications of exosomes based drug delivery. Biomed Pharmacother2024;176:116803; doi: 10.1016/j.biopha.2024.116803
49.
WeiW, CaoT, PathakJL, et al.Apigenin, a single active component of herbal extract, alleviates xerostomia via ERα-Mediated upregulation of AQP5 activation. Front Pharmacol2022;13:818116; doi: 10.3389/fphar.2022.818116
50.
WeiY, JingJ, PengZ, et al.Acacetin ameliorates insulin resistance in obesity mice through regulating Treg/Th17 balance via MiR-23b-3p/NEU1 Axis. BMC Endocr Disord2021;21(1):57; doi: 10.1186/s12902-021-00688-8
51.
WuKY, ChenWT, Chu-BédardYK, et al.Management of Sjogren’s dry eye disease-advances in ocular drug delivery offering a new hope. Pharmaceutics2022;15(1):147; doi: 10.3390/pharmaceutics15010147
52.
XuJ, ChenC, YinJ, et al.Lactate-induced mtDNA accumulation activates cGAS-STING signaling and the inflammatory response in Sjögren’s syndrome. Int J Med Sci2023;20(10):1256–1271; doi: 10.7150/ijms.83801
53.
YangJ, AmiriKI, BurkeJR, et al.BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: Involvement of nuclear factor kappaB and mitochondria pathways. Clin Cancer Res2006;12(3 Pt 1):950–960; doi: 10.1158/1078-0432.CCR-05-1220
54.
YaoC, PurwantiN, KarabasilMR, et al.Potential down-regulation of salivary gland AQP5 by LPS via cross-coupling of NF-kappaB and p-c-Jun/c-Fos. Am J Pathol2010;177(2):724–734; doi: 10.2353/ajpath.2010.090282
55.
YeL, ZuoY, YangH, et al.Specific autoantibodies and clinical phenotypes correlate with the aberrant expression of immune-related MicroRNAs in dermatomyositis. J Immunol Res2019;2019:2927061; doi: 10.1155/2019/2927061
56.
YuHC, WangST, LuMC. Dysregulated non-coding RNA expression in T cells from patients with ankylosing spondylitis contributes to its immunopathogenesis. Biomedicines2024;12(8):1873; doi: 10.3390/biomedicines12081873
57.
ZhangM, XuX, SuL, et al.Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice. J Nanobiotechnology2024;22(1):607; doi: 10.1186/s12951-024-02856-z
58.
ZhouJ, PathakJL, WuL, et al.Downregulated GPX4 in salivary gland epithelial cells contributes to salivary secretion dysfunction in Sjogren’s syndrome via lipid ROS/pSTAT4/AQP5 axis. Free Radic Biol Med2024;218:1–15; doi: 10.1016/j.freeradbiomed.2024.04.003
59.
ZhouQ, WangH, SchwartzDM, et al.Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet2016;48(1):67–73; doi: 10.1038/ng.3459
60.
ZhuQ, ChenR, WuX, et al.Bioinspired exosome-SiO2 nanohybrid therapeutic for rheumatoid arthritis treatment. Theranostics2025;15(13):6553–6571; doi: 10.7150/thno.108296
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
